English
(Updated on: Sep 1, 2021)


水本 憲治, M.D., MPH, Ph.D.
准教授
京都大学大学院総合生存学館/白眉センター

連絡先:
E-mail: mizumoto.kenji.5a(at)kyoto-u.ac.jp.SPAM
(when you send me an e-mail, please replace (at) by @ and remove ".SPAM").
Researcher profile: Researchmap, Google Scholoar, ORCID, Research Gate,

Professional area:

Area of interest:

経歴

職歴 (Research)

【英語学術論文(査読中)】

  1. Dahal S*, Mizumoto K*, Chowell G.: Investigating spatial variability in COVID-19 pandemic severity across 19 geographic areas, Spain, 2020. medRxiv. 2020.04.14.20065524.preprint(査読中).  (doi: )[URL]

【英語学術論文(全て査読有)】

  1. Chowell G, Dahal S, Bono R, Mizumoto K*.: Harnessing testing strategies and public health measures to avert COVID-19 outbreaks during ocean cruises. Sci Rep. 2021;11(1):15482. (doi:10.1038/s41598-021-95032-4.)[URL]
  2. Akhmetzhanov AR, Mizumoto K, JungS, Linton NM, Omori R, Nishiura H.: Estimation of the Actual Incidence of Coronavirus Disease (COVID-19) in Emergent Hotspots: The Example of Hokkaido, Japan during February–March 2020. J Clin Med. 2021;10(11),2392. (doi:10.3390/jcm10112392)[URL]
  3. Dahal S, Banda JM, Bento AI,Mizumoto K, Chowell G.: Characterizing all-cause excess mortality patterns during COVID-19 pandemic in Mexico. BMC Infect Dis. 2021;21:432.  (doi:10.1186/s12879-021-06122-7)[URL]
  4. Undurraga EA, Chowell G, Mizumoto K.: Case fatality risk by age from COVID-19 in a high testing setting in Latin America: Chile, March-May, 2020. Infect Dis Poverty. 2021; 10(1):11. (doi:10.1186/s40249-020-00785-1)[URL]
  5. Khare S, Dahal S, Luo R, Rothenbeg R, Mizumoto K, Chowell G.: Stillbirth Risk during the 1918 Influenza Pandemic in Arizona, USA. Epidemiologia. 2020;1(1):23-30 (doi:10.3390/epidemiologia1010005)[URL]
  6. Mizumoto K, Kagaya K, Chowell G.: Early epidemiological assessment of the transmission potential and virulence of coronavirus disease 2019 (COVID-19) in Wuhan City: China, January-February, 2020. BMC Med. 2020;18(1):217. (doi:10.1186/s12916-020-01691-x.)[URL]
  7. Munayco C*, Chowell G*,Tariq A, Undurraga EA, Mizumoto K.: Risk of death by age and gender from CoVID-19 in Peru, March-May, 2020. Aging : Aging (Albany NY) (by Medline/PubMed), Aging-US (by Web of Science). 2020;12:1945-4589. (doi:10.18632/aging.103687)[URL]
  8. Shim E, Mizumoto K, Choi W, Chowell G.: Estimating the risk of COVID-19 death during the course of the outbreak in Korea, February- May, 2020. J Clin Med. 2020; E1641. (doi:10.3390/jcm9061641)[URL]
  9. Oshitani H, the Experts Members of The National COVID-19 Cluster Taskforce at Ministry of Health, Labour and Welfare, Japan.: Cluster-based approach to Coronavirus Disease 2019 (COVID-19) response in Japan—February–April 2020. Jpn J Infect Dis.2020.  (doi:10.7883/yoken.JJID.2020.363.)[URL]
  10. Mizumoto K*, Dahal S*, Chowell G.: Spatial variability in the risk of death from COVID-19 in 20 regions of Italy. Int J Tuberc Lung Dis.2020;24(8)829-837  (doi:10.5588/ijtld.20.0262.)
  11. Mizumoto K, Kagaya K, Chowell G.: Effect of the Wet Market on the coronavirus disease (COVID-19) transmission dynamics in China, 2019-2020. Int J Infect Dis. 2020;97:96-101.  (doi: 10.1016/j.ijid.2020.04.080)[URL]
  12. Omori R, Mizumoto K, Nishiura H.: Ascertainment rate of novel coronavirus disease (COVID-19) in Japan. Int J Infect Dis. 2020;S1201-9712(20)30292-7. (doi: 10.1016/j.ijid.2020.04.080.)[URL]
  13. Omori R, Mizumoto K, Chowell G.: Changes in testing rates could mask the novel coronavirus disease (COVID-19) growth rate. Int J Infect Dis. 2020.pii: S1201-9712(20)30236-8.  (doi:10.1016/j.ijid.2020.04.021)[URL]
  14. Chowell G, Mizumoto K.: The COVID-19 pandemic in the USA: what might we expect? Lancet. 2020;395:1093-1094. Comment. (doi:10.1016/S0140-6736(20)30743-1)[doi]
  15. Mizumoto K, Chowell G: Transmission potential of the novel coronavirus (COVID-19) onboard the diamond Princess Cruises Ship, 2020. Infect Dis Model. 2020;5:264-270. (doi:doi: 10.1016/j.idm.2020.02.003)[doi]
  16. Mizumoto K, Chowell G.: Estimating Risk for Death from 2019 Novel Coronavirus Disease, China, January–February 2020. Emerg Infect Dis. 2020;26(6):1251-1256. (doi:10.3201/eid2606.200233)[doi]
  17. Mizumoto K, Kagaya K, Zarebski A, Chowell G: Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020. Euro Surveill. 2020;25(10). (doi: )[doi]
  18. Mizumoto K, Chowell G.: Temporary fertility decline after a large rubella outbreak, Japan. Emerg Infect Dis. 2020; 26(6):1122-1129.  (doi:10.3201/eid2606.181718)[doi]
  19. Mizumoto K, Tariq A, Roosa K, Kong J, Yan P, Chowell G.: Spatial variability in the reproduction number of Ebola virus disease, Democratic Republic of the Congo, January–September 2019. Euro Surveill. 2019;24(42):pii=1900588. (doi: 10.2807/1560-7917.ES.2019.24.42.1900588.)[doi]
  20. Suzuki A, Mizumoto K, Akhmetzhanov AR, Nishiura H.: Interaction Among Influenza Viruses A/H1N1, A/H3N2, and B in Japan. Int J Environ Res Public Health. 2019;16(21). (doi: 10.3390/ijerph16214179.)[doi]
  21. Tariq A, Roosa K, Mizumoto K, Chowell G.: Assessing reporting delays and the effective reproduction number: The 2018-19 Ebola epidemic in DRC, May 2018-January 2019. Epidemics. 2019;26:128-133. (doi: 10.1016/j.epidem.2019.01.003.)[doi]
  22. Chowell G, Mizumoto K, Juan B, Silvestro P, Charles P.: Assessing the potential impact of vector-borne disease transmission following heavy rainfall events: A mathematical framework. Philosophical Transactions B. 2019;374:20180272. (doi:10.1098/rstb.2018.0272.)[doi]
  23. Dahal S, Mizumoto K, Bolin B, Viboud C, Chowell G.: Natality decline and Spatial Variation in Excess Death Rates During the 1918-1920 Influenza Pandemic in Arizona, USA. Am J Epidemiol. 2018;187:2577-2584. (doi:10.1093/aje/kwy146)[doi]
  24. Mizumoto K, Kobayashi T, Chowell G: Transmission potential of modified measles during an outbreak, Japan, March–May 2018. Euro Surveill. 2018;23(24):pii=1800239. (doi:10.2807/1560-7917.ES.2018.23.24.1800239)[doi]
  25. Dahal S, Jenner M, Dinh L, Mizumoto K, Viboud C, Chowell G: Excess mortality patterns during 1918-1921 influenza pandemic in the state of Arizona,USA. Annals of Epidemiology. 2017;pii:S1047-2797:30682-8. (doi: 10.1016/j.annepidem.2017.12.005)[doi]
  26. Nishiura H, Mizumoto K, Asai Y: Assessing the transmission dynamics of measles in Japan, 2016. Epidemics. 2017;20:67-72. (doi: 10.1016/j.epidem.2017.03.005.)[doi]
  27. Dinh L, Chowell G, Mizumoto K, Nishiura H: Estimating the subcritical transmissibility of the Zika outbreak in the State of Florida, USA, 2016. Theor Biol Med Model. 2016;13:20. (doi: 10.1186/s12976-016-0046-1.)[doi]
  28. Nah K, Mizumoto K, Miyamatsu Y, Yasuda Y, Kinoshita R, Nishiura H: Estimating risks of importation and local transmission of Zika virus infection. PeerJ. 2016;4:e1904. [journal]
  29. Nishiura H, Mizumoto K, Villamil-Gomez WE, Rodriguez-Morales AJ: Preliminary estimation of the basic reproduction number of Zika virus infection during Colombia epidemic, 2015-2016. Travel Med Infect Dis. 2016;14:274-6. (doi: 10.1016/j.tmaid.2016.03.016)[doi]
  30. Nishiura H, Mizumoto K, Rock KS, Yasuda Y, Kinoshita R, Miyamatsu Y: A theoretical estimate of the risk of microcephaly during pregnancy with Zika virus infection. Epidemics. 2016;15:66-70. (doi: 10.1016/j.epidem.2016.03.001.)[doi]
  31. Nishiura H, Kinoshita R, Mizumoto K, Yasuda Y, Nah K: Transmission potential of Zika virus infection in the South Pacific. Int J Infect Dis. 2016;45:95-7. (doi: 10.1016/j.ijid.2016.02.017.)[doi]
  32. Nishiura H, Endo A, Saitoh M, Kinoshita R, Ueno R, Nakaoka S, Miyamatsu Y, Dong Y, Chowell G, Mizumoto K: Identifying determinants of heterogeneous transmission dynamics of the Middle East respiratory syndrome (MERS) outbreak in the Republic of Korea, 2015: a retrospective epidemiological analysis. BMJ Open. 2016;6:e009936. (doi: 10.1136/bmjopen-2015-009936.)[doi]
  33. Nishiura H, Miyamatsu Y, Mizumoto K: Objective Determination of End of MERS Outbreak, South Korea, 2015. Emerg Infect Dis. 2016;22:146-8. Letter (doi: 10.3201/eid2201.151383.)[doi]
  34. Mizumoto K , Endo A, Chowell G, Miyamatsu Y, Saitoh M, Nishiura H: Real-time characterization of risks of death associated with the Middle East respiratory syndrome (MERS) in the Republic of Korea, 2015. BMC Med. 2015;13. (doi: 10.1186/s12916-015-0468-3.)[doi]
  35. Mizumoto K, Saitoh M, Chowell G, Miyamatsu Y, Nishiura H: Estimating the risk of Middle East respiratory syndrome (MERS) death during the course of the outbreak in the Republic of Korea, 2015. Int J Infect Dis. 2015;39. (doi: 10.1016/j.ijid.2015.08.005.)[doi]
  36. Nishiura H, Kinoshita R, Miyamatsu Y,Mizumoto K: Investigating the immunizing effect of the rubella epidemic in Japan, 2012-14.  Int J Infect Dis. 2015;38. (doi: 10.1016/j.ijid.2015.07.006.)[doi]
  37. Mizumoto K, Ejima K, Yamamoto T, Nishiura H: On the risk of severe dengue during secondary infection: A systematic review coupled with mathematical modeling. Journal of Vector Borne Diseases. 2014;51:153-64. [journal]
  38. Nishiura H, Ejima K, Mizumoto K, Nakaoka S, Inaba H, Imoto S, Yamaguchi R, Saito MM: Cost-effective length and timing of school closure during an influenza pandemic depend on the severity. Theor Biol Med Model. 2014;11:5. (doi: 10.1186/1742-4682-11-5.)[doi]
  39. Nishiura H, Ejima K, Mizumoto K: Missing information in animal surveillance of MERS-CoV. Lancet Infectious Diseases.  2014;14:100. Correspondence. (doi: 10.1016/S1473-3099(13)70699-6)[doi]
  40. Nishiura H, Mizumoto K, Ejima K: How to interpret the transmissibility of novel influenza A(H7N9): an analysis of initial epidemiological data of human cases from China. Theoretical Biology and Medical Modelling. 2013;10:30. (doi: 10.1186/1742-4682-10-30)[doi]
  41. Mizumoto K, Ejima K, Yamamoto T, Nishiura H: Vaccination and clinical severity: Is the effectiveness of contact tracing and case isolation hampered by past vaccination? International Journal of Environmental Research and Public Health. 2013;10:816-829. (doi: 10.3390/ijerph10030816)[doi]
  42. Nishiura H, Mizumoto K: Epidemiological determinants of successful vaccine development. International Journal of Medical Sciences. 2013;10:382-384 (doi: 10.7150/ijms.5689)[doi]
  43. Mizumoto K, Yamamoto T, Nishiura H: Age-dependent estimates of the epidemiological impact of pandemic influenza (H1N1-2009) in Japan. Computational and Mathematical Methods in Medicine. 2013;2013:637064. (doi: 10.1155/2013/637064)[doi]
  44. Mizumoto K, Nishiura H, Yamamoto T: Effectiveness of antiviral prophylaxis coupled with contact tracing in reducing the transmission of the influenza A (H1N1-2009): A systematic review. Theoretical Biology and Medical Modelling. 2013;10:4. (doi: 10.1186/1742-4682-10-4)[doi]
  45. Mizumoto K, Yamamoto T, Nishiura H: Contact behaviour of children and parental employment behaviour during school closure against the pandemic influenza A (H1N1-2009) in Japan. The Journal of International Medical Research. 2013;41:716-724. (doi: 10.1177/0300060513478061)[doi]
  46. Nishiura H, Mizumoto K, Ejima K, Zhong Y, Cowling BJ, Omori R: Incubation period as part of the case definition of severe respiratory illness caused by a novel coronavirus. Eurosurveillance. 2012;17:pii=20296. [journal]

【和文学術論文(査読無)】

  1. 水本憲治, 季節性インフルエンザの疾病負荷推定, RIMS 研究集会報告集 1937, 157-162, 2015
  2. 水本憲治, 予防内服用抗インフルエンザウイルス薬の備蓄政策に対する費用効果分析, MI Lecture Note 60, 114-120, 2014
  3. 水本憲治, 確率論的モデルを用いた排除期における麻疹流行と予防接種効果, RIMS 研究集会報告集 1937, 157-162, 2014

【総  説】

  1. 水本憲治, これからのインフルエンザ臨床と感染対策-どのようにインフルエンザは流行しているか. 臨床看護 37, 1738-1744, 2011
  2. 水本憲治, 小児におけるインフルエンザ対策-行政におけるインフルエンザ対策. 小児看護 34, 1325-1330, 2011
  3. 水本憲治, インフルエンザ対策のすべて-H1N1 2009 の総括と今後の対策-行政の立場から. INFECTION CONTROL 19, 1150-1151, 2010

【学会発表】国際学会口頭発表:

【学会発表】国際学会ポスター発表:

【学会発表】国内学会招待講演

 

【学会発表】国内学会口頭発表

【学会発表】国内学会ポスター発表

研究資金/受賞歴:

その他の研究プロジェクト:

教育歴

ワークショップ参加歴

所属学会